Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward?

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Brander, DM

Published Date

  • February 2017

Published In

Volume / Issue

  • 176 / 3

Start / End Page

  • 337 - 340

PubMed ID

  • 27984636

Pubmed Central ID

  • 27984636

Electronic International Standard Serial Number (EISSN)

  • 1365-2141

Digital Object Identifier (DOI)

  • 10.1111/bjh.14446

Language

  • eng

Conference Location

  • England